EV/EBITDA
-1.32
-0.15-12.82%
17 min ago
Summary
- As of March 10, 2025, CMMB EV/EBITDA is -1.32, with a fall of -0.15 (-12.82%) during the most recent trading day.
- Over the past year, CMMB EV/EBITDA has dropped by -1.25 (-1785.71%).
- CMMB EV/EBITDA is now -540.00% below its all-time high of 0.30.
Performance
CMMB EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
CMMB EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -12.8% | +13.1% | +9.8% |
| 1 m1 month | +38.9% | -38.6% | -32.7% |
| 3 m3 months | +29.4% | -29.4% | -24.3% |
| 6 m6 months | +38.0% | -40.5% | -36.5% |
| ytdytd | +30.9% | -30.8% | -25.6% |
| 1 y1 year | -1785.7% | +929.8% | +76.3% |
| 5 y5 years | - | - | -90.6% |
CMMB EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -12.8% | -2.27 | +41.9% | |
| 3 m | 3-month | -1.17 | -12.8% | -2.64 | +50.0% |
| 6 m | 6-month | -0.93 | -41.9% | -2.64 | +50.0% |
| 1 y | 1-year | -0.05 | -2540.0% | -2.64 | +50.0% |
| 3 y | 3-year | 0.30 | -540.0% | -3.71 | +64.4% |
| 5 y | 5-year | 0.30 | -540.0% | -32.26 | +95.9% |
| alltime | all time | 0.30 | -540.0% | -32.26 | +95.9% |
Chemomab Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -1.32(-30.9%) |
| 2024 | -1.91(-2828.6%) |
| Date | Value |
|---|---|
| 2023 | 0.07(-109.1%) |
| 2022 | -0.77(-85.1%) |
| 2021 | -5.18 |
FAQ
- What is Chemomab Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Chemomab Therapeutics?
- What is CMMB EV/EBITDA year-to-date change?
- What is Chemomab Therapeutics EV/EBITDA year-on-year change?
What is Chemomab Therapeutics EV/EBITDA?
The current EV/EBITDA of CMMB is -1.32
What is the all time high EV/EBITDA for Chemomab Therapeutics?
Chemomab Therapeutics all-time high EV/EBITDA is 0.30
What is CMMB EV/EBITDA year-to-date change?
Chemomab Therapeutics EV/EBITDA has changed by +0.59 (+30.89%) since the beginning of the year
What is Chemomab Therapeutics EV/EBITDA year-on-year change?
Over the past year, CMMB EV/EBITDA has changed by -1.25 (-1785.71%)